THE ROLE OF CHEMOTHERAPY IN LOW-GRADE SEROUS OVARIAN CARCINOMA: REPORT OF TWO CASES

被引：0
|
作者：
Moreira-Barros, J. [1 ]
Vaz, I. [2 ]
Gunthert, A. [2 ]
机构：
[1] Hosp Pedro Hispano, Obstet & Gynecol, Marco De Canaveses, Portugal
[2] Frauenklin, Luzerner Kantonsspital, Luzern, Switzerland
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2017年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO7-1450
引用
收藏
页码：1982 / 1982
页数：1
相关论文
共 50 条
  • [31] Molecular Analysis of High-Grade Serous Ovarian Carcinoma Exhibiting Low-Grade Serous Carcinoma and Serous Borderline Tumor
    Kanno, Kosuke
    Nakayama, Kentaro
    Razia, Sultana
    Islam, Sohel Hasibul
    Farzana, Zahan Umme
    Sonia, Shahataj Begum
    Sasamori, Hiroki
    Yamashita, Hitomi
    Ishibashi, Tomoka
    Ishikawa, Masako
    Imamura, Kayo
    Ishikawa, Noriyoshi
    Kyo, Satoru
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (09) : 9376 - 9385
  • [32] Ovarian Combined Serous Borderline Tumor/Low-grade Serous Carcinoma and Mesonephric-like Lesion: Report of 2 Cases With New Observations
    Nilforoushan, Neshat
    Liu, Lian
    Finkelman, Brian S.
    Andersen, John
    Liu, Ying
    James, Jeffrey
    Hung, Chien-Fu
    Wu, T. -C.
    Vang, Russell
    Xing, Deyin
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2023, 42 (02) : 182 - 191
  • [33] Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma
    Santillan, A.
    Kim, Y. W.
    Zahurak, M. L.
    Gardner, G. J.
    Giuntoli, R. L., II
    Shih, I. M.
    Bristow, R. E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (03) : 601 - 606
  • [34] Hormone receptor expression and outcomes in low-grade serous ovarian carcinoma
    Fernandez, Marta Llaurado
    Dawson, Amy
    Kim, Hannah
    Lam, Nicole
    Russell, Holly
    Bruce, Maegan
    Bittner, Madison
    Hoenisch, Joshua
    Scott, Stephanie A.
    Talhouk, Aline
    Chiu, Derek
    Provencher, Diane
    Nourmoussavi, Melica
    DiMattia, Gabriel
    Lee, Cheng-Han
    Gilks, C. Blake
    Kobel, Martin
    Carey, Mark S.
    GYNECOLOGIC ONCOLOGY, 2020, 157 (01) : 12 - 20
  • [35] Response to chemotherapy in relapsed low-grade serous ovarian carcinoma: Royal Marsden series of 46 patients
    McLachlan, J. M.
    Tunariu, N.
    Lima, J. P.
    George, A.
    Gore, M.
    Kaye, S.
    Banerjee, S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [36] Impact of adjuvant chemotherapy on the overall survival of patients with advanced stage low-grade serous ovarian carcinoma
    Nasioudis, Dimitrios
    George, Erin
    Latif, Nawar
    Ko, Emily
    Haggerty, Ashley
    Cory, Lori
    Giuntoli, Robert
    Kim, Sarah
    Morgan, Mark
    Simpkins, Fiona
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S82 - S82
  • [37] Disparities in care among patients with low-grade serous ovarian carcinoma
    Siemon, J.
    Galli, J.
    Slomovitz, B.
    Schlumbrecht, M.
    GYNECOLOGIC ONCOLOGY, 2020, 157 (01) : 46 - 54
  • [38] Survival outcomes for patients with recurrent low-grade serous ovarian carcinoma
    Yazigi, A.
    Ray-Coquard, I. L.
    Pujade-Lauraine, E.
    Lecuru, F.
    Bonsang-Kitzis, H.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 93 - 94
  • [39] Molecular Surrogate Subtypes of Ovarian and Peritoneal Low-grade Serous Carcinoma
    Da-Anoy, Annalyn
    Kang, Eun Young
    Lee, Cheng Han
    Cheasley, Dane
    Fernandez, Marta Llaurado
    Carey, Mark S.
    Cameron, Anna
    Kobel, Martin
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2024, 43 (06) : 617 - 625
  • [40] Efficacy of Pegylated Liposomal Doxorubicin in Low-Grade Serous Ovarian Carcinoma
    Rose, Peter G.
    Radeva, Milena
    Michener, Chad M.
    Link, Nicholas
    Adbul-Karim, Fadi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (05) : 907 - 911
12345